CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
NaCl 0.9% +2 moredrug
Likely dose
NaCl 0.9% 2 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02182999
NCT02182999Phase 4Completed

Continuous Wound Infiltration After Hallux Valgus Surgery A Prospective, Randomized, Double-blind and Placebo-controlled Single-center Trial

Medical University Innsbruck·interventional·Posted Jul 8, 2014·Updated Aug 13, 2018

In Brief

A Phase 4 clinical trial evaluating Wound infiltration catheter, NaCl 0.9%, and 1 other intervention for Hallux Valgus. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The aim of this study is to investigate the effect of continuous wound infiltration with ropivacaine in comparison to standard pain management after elective distal metatarsal osteotomy for postoperative pain control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHallux Valgus
CountriesAustria
Collaborators--

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJul 8, 2014
Enrollment StartMay 1, 2014
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.0 years ago

Interventions

Wound infiltration catheterdevice

Wound catheter with multiple and laterally aligned holes is inserted through the intact skin via an 16G iv catheter 2 cm proximal-laterally from the proximal end of the dorsomedial skin incision and placed subcutaneously through the wound and medially around the first metatarsal so that the tip projects into the interdigital space 1/2.

NaCl 0.9%drug

The catheter is connected to the perfusor line filled with saline 0.9% to allow continuous wound infiltration at a rate of 2 ml/h for 24 hours.

Ropivacaine 0.2%drug

The catheter is connected to the perfusor line filled with Ropivacaine 0.2% to allow continuous wound infiltration at a rate of 2 ml/h for 24 hours.